Shares of Telix Pharmaceuticals (ASX:TLX) Tuesday saw an increase of as much as 11.8%, leading its share price to A$10.940.

The stock’s performance marks its best day since April 18, assuming gains are sustained.

Telix Pharmaceuticals (ASX:TLX) secured the position of leading gainer on the benchmark index.

The company stated a nine-fold increase in HY total group revenue, and was able to narrow its HY net loss after tax.

Telix Pharmaceuticals (ASX:TLX) reached its highest level since August 7.

Furthermore, the TLX share price has experienced a rise of approximately 35% this year, as of the last closing, compared to a 1.6% increase in the benchmark index.

Telix Pharmaceuticals (ASX:TLX) is a biopharmaceutical company which focuses on the development and commercialization of radiopharmaceuticals for therapeutic applications.